These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Preferences for oral PrEP dosing among adolescent boys and young men in three sub-Saharan African countries. Kakande A, Ssemata AS, Muhumuza R, Atujuna M, Abaasa A, Ndekezi D, Tshabalala G, Nematadzira T, Hornschuh S, Nomvuyo M, Ahmed N, Maluadzi M, Anne Weiss H, Webb E, Stranix-Chibanda L, Janine Dietrich J, Seeley J, Fox J. PLoS One; 2023; 18(10):e0285132. PubMed ID: 37812644 [Abstract] [Full Text] [Related]
5. Increased condom use among key populations using oral PrEP in Kenya: results from large scale programmatic surveillance. Manguro GO, Musau AM, Were DK, Tengah S, Wakhutu B, Reed J, Plotkin M, Luchters S, Gichangi P, Temmerman M. BMC Public Health; 2022 Feb 14; 22(1):304. PubMed ID: 35164707 [Abstract] [Full Text] [Related]
6. Home-based pre-exposure prophylaxis (PrEP) services for gay and bisexual men: An opportunity to address barriers to PrEP uptake and persistence. John SA, Rendina HJ, Grov C, Parsons JT. PLoS One; 2017 Feb 14; 12(12):e0189794. PubMed ID: 29281688 [Abstract] [Full Text] [Related]
8. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study. Haribhai S, Khadka N, Mvududu R, Mashele N, Bekker LG, Gorbach P, Coates TJ, Myer L, Joseph Davey DL. Int J STD AIDS; 2023 Jul 14; 34(8):548-556. PubMed ID: 36947792 [Abstract] [Full Text] [Related]
9. Family influences on oral PrEP use among adolescent girls and young women in Kenya and South Africa. Ndimande-Khoza MN, Katz AWK, Moretlwe-Delany S, Travill D, Rousseau E, Omollo V, Morton J, Johnson R, Bekker LG, Bukusi EA, Baeten J, Celum C, van der Straten A, Roberts ST. PLoS One; 2023 Jul 14; 18(11):e0292529. PubMed ID: 37963171 [Abstract] [Full Text] [Related]
11. Retention in event-driven PrEP among young Thai men who have sex with men at risk of HIV acquisition. Traikiatphum J, Wongharn P, Moonwong J, Songtaweesin WN, Vitsupakorn S, Premgamone A, Kawichai S, Puthanakit T. Int J STD AIDS; 2022 Jul 14; 33(8):799-805. PubMed ID: 35653585 [Abstract] [Full Text] [Related]
12. Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol. Sharma M, Chris A, Chan A, Knox DC, Wilton J, McEwen O, Mishra S, Grace D, Rogers T, Bayoumi AM, Maxwell J, Shahin R, Bogoch I, Gilbert M, Tan DHS. BMC Health Serv Res; 2018 Jul 03; 18(1):513. PubMed ID: 29970087 [Abstract] [Full Text] [Related]
13. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya. Mugwanya KK, Pintye J, Kinuthia J, Abuna F, Lagat H, Begnel ER, Dettinger JC, John-Stewart G, Baeten JM, PrEP Implementation for Young Women and Adolescents (PrIYA) Program. PLoS Med; 2019 Sep 03; 16(9):e1002885. PubMed ID: 31479452 [Abstract] [Full Text] [Related]
14. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project. Celum CL, Bukusi EA, Bekker LG, Delany-Moretlwe S, Kidoguchi L, Omollo V, Rousseau E, Travill D, Morton JF, Mogaka F, O'Malley G, Barnabee G, van der Straten A, Donnell D, Parikh UM, Kudrick L, Anderson PL, Haberer JE, Wu L, Heffron R, Johnson R, Morrison S, Baeten JM, POWER Study Team. J Int AIDS Soc; 2022 Jul 03; 25(7):e25962. PubMed ID: 35822945 [Abstract] [Full Text] [Related]
15. Pre-Exposure Prophylaxis for HIV Prevention in Women: Current Status and Future Directions. Hodges-Mameletzis I, Fonner VA, Dalal S, Mugo N, Msimanga-Radebe B, Baggaley R. Drugs; 2019 Aug 03; 79(12):1263-1276. PubMed ID: 31309457 [Abstract] [Full Text] [Related]